scholarly article | Q13442814 |
P356 | DOI | 10.1161/01.HYP.1.3.287 |
P953 | full work available at URL | https://www.ahajournals.org/doi/pdf/10.1161/01.HYP.1.3.287 |
P698 | PubMed publication ID | 399240 |
P2093 | author name string | H. Saito | |
W. G. Walker | |||
P. K. Whelton | |||
J. Hermann | |||
R. P. Russell | |||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | internal medicine | Q11180 |
P304 | page(s) | 287-291 | |
P577 | publication date | 1979-05-01 | |
P1433 | published in | Hypertension | Q5958695 |
P1476 | title | Relation between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects | |
P478 | volume | 1 |
Q39243882 | A disappearing urban/rural blood pressure difference in Nigerian children: an evaluation of possible determining factors |
Q43229219 | A growing chain of evidence linking genetic variation in angiotensinogen with essential hypertension: focus on "a haplotype of human angiotensinogen gene containing -217A increases blood pressure in transgenic mice compared with -217G," by Jain et a |
Q42807788 | A haplotype of angiotensinogen gene that is associated with essential hypertension increases its promoter activity in adipocytes |
Q37200092 | A haplotype of human angiotensinogen gene containing -217A increases blood pressure in transgenic mice compared with -217G. |
Q36107897 | A haplotype of the angiotensinogen gene is associated with hypertension in african americans |
Q50210299 | A highly selective, colorimetric, and environment-sensitive optical potassium ion sensor |
Q38332479 | A single-nucleotide polymorphism in human angiotensinogen gene is associated with essential hypertension and affects glucocorticoid induced promoter activity |
Q84098505 | AGT genetic variation, plasma AGT, and blood pressure: An analysis of the Utah Genetic Reference Project pedigrees |
Q44714552 | Adrenocorticosteroid excretion in salt-sensitive and salt-resistant spontaneously hypertensive rats |
Q46158214 | Aldosterone and alterations of hypertension-related vascular function in African Americans |
Q37660912 | Aldosterone and arterial hypertension |
Q45129805 | Aldosterone-to-renin ratio and home blood pressure in subjects with higher and lower sodium intake: the Ohasama study |
Q36518364 | An association between the renin angiotensin system, blood pressure and potassium intake |
Q73589683 | Angiotensin I-converting enzyme and angiotensinogen gene polymorphisms in non-insulin-dependent diabetes mellitus. Lack of relationship with diabetic nephropathy and retinopathy in a Caucasian Mediterranean population |
Q34099697 | Angiotensin II induces gene transcription through cell-type-dependent effects on the nuclear factor-kappaB (NF-kappaB) transcription factor |
Q44413512 | Angiotensin-II-induced enhanced expression of Gi proteins is attenuated by losartan in A10 vascular smooth muscle cells: role of AT1receptors |
Q36622923 | Angiotensinogen (AGT) M235T, AGT T174M and Angiotensin-1-Converting Enzyme (ACE) I/D Gene Polymorphisms in Essential Hypertension: Effects on Ramipril Efficacy |
Q51564497 | Angiotensinogen M235T polymorphism is associated with plasma angiotensinogen and cardiovascular disease. |
Q33917325 | Angiotensinogen variants and human hypertension |
Q41342574 | Angiotensinogen: molecular biology, biochemistry and physiology |
Q34291477 | Aspects of gene polymorphisms in cardiovascular disease: the renin-angiotensin system |
Q37726913 | Association of angiotensinogen gene SNPs and haplotypes with risk of hypertension in eastern Indian population |
Q44221049 | Associations of genetic polymorphisms in the renin-angiotensin system with central aortic and ambulatory blood pressure in type 2 diabetic patients. |
Q44199086 | Blood pressure regulation, peripheral renin activity and aldosterone in patients with pyelonephritic renal scarring |
Q43725606 | Both alleles of the M235T polymorphism of the angiotensinogen gene can be a risk factor for myocardial infarction. |
Q39666932 | Cations and hypertension: sodium, potassium, calcium, and magnesium. |
Q44005934 | Comparison of circulating and local adipose tissue renin-angiotensin system in normotensive and hypertensive obese subjects |
Q56893651 | Detection of putative functional angiotensinogen (AGT) gene variants controlling plasma AGT levels by combined segregation-linkage analysis |
Q93674498 | Effect of potassium depletion on two-kidney, one-clip renovascular hypertension in the rat |
Q35170659 | Efficacy of potassium and magnesium in essential hypertension: a double-blind, placebo controlled, crossover study |
Q38360767 | Environmental origins of hypertension: phylogeny, ontogeny and epigenetics |
Q44095530 | Essential arterial hypertension and polymorphism of angiotensinogen M235T gene. |
Q36876534 | Estimating 24-hour urinary sodium excretion from casual urinary sodium concentrations in Western populations: the INTERSALT study |
Q71698252 | Examination of two genetic polymorphisms within the renin-angiotensin system: no evidence for an association with nephropathy in IDDM |
Q22001496 | Exon-I is involved in positive as well as negative regulation of human angiotensinogen gene expression |
Q37678564 | Gene variants of the renin-angiotensin system and hypertension: from a trough of disillusionment to a welcome phase of enlightenment? |
Q34498129 | Genetic control of blood pressure and the angiotensinogen locus |
Q40138023 | HNF-1alpha plays an important role in IL-6-induced expression of the human angiotensinogen gene |
Q35250479 | Haplotypes of angiotensinogen in essential hypertension |
Q34030867 | Hypercontrols in genotype-phenotype analysis reveal ancestral haplotypes associated with essential hypertension. |
Q39666914 | Hypertension in blacks |
Q46037023 | Hypertension, insulin resistance, and aldosterone: sex-specific relationships. |
Q41554322 | Insulin receptor gene in hypertension |
Q36306876 | JANUS under stress--role of JAK/STAT signaling pathway in vascular diseases |
Q73739628 | Lack of association between variants of the angiotensinogen gene and the risk of coronary artery disease in middle-aged Japanese men |
Q33638787 | Lifestyle modifications to prevent and control hypertension. 6. Recommendations on potassium, magnesium and calcium. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease [...] |
Q36079020 | Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases |
Q40423457 | Liver-specific angiotensinogen suppression: an old yet novel target for blood pressure control through RAS inhibition? |
Q40095834 | Magnesium, electrolyte transport and coronary vascular tone |
Q33567189 | Maternal high-fat diet programs rat offspring hypertension and activates the adipose renin-angiotensin system |
Q72533018 | Moderate potassium supplementation in essential hypertension |
Q41075195 | Molecular variation of the human angiotensinogen core promoter element located between the TATA box and transcription initiation site affects its transcriptional activity |
Q40863888 | Nutrition and diseases of women: cardiovascular disorders |
Q30361051 | Obesity and dementia: adipokines interact with the brain. |
Q38020091 | Potassium and calcium intake, excretion, and homeostasis in blacks, and their relation to blood pressure |
Q44033435 | Potassium in hypertension |
Q40888901 | Potassium intake and cardiovascular reactivity in children with risk factors for essential hypertension |
Q37725914 | Proteomics Analysis to Identify and Characterize the Biomarkers and Physical Activities of Non-Frail and Frail Older Adults |
Q73287353 | Relationship between hepatic angiotensinogen mRNA expression and plasma angiotensinogen in patients with chronic hepatitis |
Q41219799 | Remote control of macrophage production by cancer |
Q41609757 | Renin-angiotensin system: genes to bedside |
Q44335653 | Renin-angiotensin-aldosterone system loci and multilocus interactions in young-onset essential hypertension. |
Q33684372 | Salt and blood pressure in Belgium |
Q34401786 | Salt and hypertension: a phylogenetic perspective. |
Q36833242 | Salt intake and the association with blood pressure in young Iranian children: first report from the middle East and north Africa |
Q71046898 | Sodium Excess or Potassium Lack as a Cause of Hypertension: A Discussion Paper |
Q71392867 | Sodium and potassium intake and blood pressure |
Q86945819 | Targeting of hepatic angiotensinogen using chemically modified siRNAs results in significant and sustained blood pressure lowering in a rat model of hypertension |
Q41525211 | The Effects of Potassium Depletion and Supplementation on Blood Pressure: A Clinical Review |
Q38332289 | The impacts of obesity on the cardiovascular and renal systems: cascade of events and therapeutic approaches |
Q37853048 | The importance of potassium in managing hypertension |
Q43988961 | The relationship between angiotensinogen gene polymorphisms and essential hypertension in a Northern Han Chinese population |
Q37762163 | The role of potassium in the pathogenesis and treatment of hypertension |
Q35552198 | The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children |
Q33610174 | Transcriptional regulation of angiotensinogen gene expression. |
Q35108463 | Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice |
Q35461116 | Variants and haplotypes in angiotensinogen gene are associated with plasmatic angiotensinogen level in Mexican population |
Q44046291 | Variation at the M235T locus of the angiotensinogen gene and essential hypertension: a population-based case-control study from Rochester, Minnesota |
Q73540804 | [Role of the angiotensinogen gene for essential hypertension] |
Search more.